Our MD C Surendran on @ETNOWlive: FY27 revenue growth guidance of 16% on track, driven by specialty diagnostics and Tier 2/3 expansion. Also covered margins, lab-to-centre ratio, and oncology and genomics.
youtube.com/watch?v=HMXPHpBp…
Metropolis Healthcare reports strong Q2 FY27 performance.
Read more in the Press Release: metropolisindia.com/newdata/…
#Q2FY27 #H1FY27 #MetropolisHealthcare #QuarterlyResults #SpecialtyDiagnostics #PreventiveHealthcare #ItsGoodToBeSure
Why must adolescent agency be at the heart of sustainable social change? Dr Duru Shah, Chairperson, Metropolis Foundation, explains in an exclusive interview with The CSR universe, sharing how our ARSH programme empowers young people at the grassroots.
🔗 thecsruniverse.com/articles/…
Proud Moment! 🏆
Our Managing Director, Mr. Surendran Chemmenkotil, has been recognised among India’s Impactful Healthcare Leaders 2026 by @ET_Edge , The Times Group, at the Future of Healthcare Conclave 2026 in Mumbai.
Proud to share that Metropolis Healthcare has been recognised with the “Best Overseas Diagnostics & Laboratory Network” award at #SANJEEVANI2026 – Bharat Global Health Expo, organised by SEPC in association with AHPI & Business World.
#Proudmoment for @CoreDiagnostics, a unit of Metropolis Healthcare, recognised as the North Winner – Excellence in Precision Diagnostics & Personalised Care at the ET Healthcare Awards 2026, hosted by @ETHealthWorld @MetropolisLab
What does it take to build a business that creates value for decades, not just quarters?
In her Beyond Valuation article in @BWBusinessworld, our Executive Chairperson Ms. @AmeeraShah reflects on thinking long term, taking ownership and building institutions that last.
Pleased to share that Metropolis Healthcare has been recognised as the National Winner – Diagnostic Chain of the Year at the ET Healthcare Awards 2026 by @ETHealthWorld. A recognition of our commitment to quality, innovation, scale, and patient-centric diagnostics.@MetropolisLab












